Monday 23 February 2015

Friday 20 February 2015

Are you interested in biomedical research funding opportunities?


SFI, the HRB and the Wellcome Trust will co-host two information days about funding available under the SFI-HRB-Wellcome Trust Biomedical Research Partnership. They will take place on 25 March in Galway, and 26 March in Dublin

The full programme, timetable and registration details for each location are available from the links below. Please register by selecting the breakout session in your preferred location that is most relevant to your career stage. The same information will be presented in each venue by the Wellcome Trust.
Attendance is free, but you will need to register for your preferred location.
Queries can be e-mailed to contact(at)wellcome-ireland.com

Thursday 19 February 2015

Understanding resistance to cancer drugs

Pioneering new drug treatments are showing great promise in the treatment of many cancers.
The BBC's Panorama programme spent 18 months following a group of patients at the Royal Marsden Hospital in London on a range of treatments, many of which target specific genetic mutations which drive cancer growth.
Some patients whose cancer had spread and been given months to live have kept the disease at bay for years, and the treatments increase the chance of curing patients whose disease is caught early enough.
The trials at the Royal Marsden are part of a unique collaboration with the Institute of Cancer Research - where doctors divide their time between studying the disease in the laboratory and seeing patients in hospital.
Dr Udai Banerji works at The Institute of Cancer Research, London, and The Royal Marsden.

Wednesday 18 February 2015

Former Dean of Medicine presented with Award for Outstanding Contribution to Respiratory Medicine

Professor Pat Finnegan receiving the Irish Thoracic Society Award for Outstanding Contribution to Respiratory Medicine pictured with Professor JJ Gilmartin and Professor Anthony O’Regan, President, the Irish Thoracic Society.
Professor Pat Finnegan, former Dean of Medicine at NUI Galway and retired respiratory consultant at University College Hospital Galway, was presented with the Irish Thoracic Society Award for Outstanding Contribution to Respiratory Medicine at the Society’s recent Annual Gala Dinner.
On presenting the award, friend and colleague Professor JJ Gilmartin paid tribute to Professor Finnegan and outlined the highlights of a career marked by outstanding achievements as both teacher and innovator.  
A graduate of University College Galway (now NUI Galway) Professor Finnegan spent the early stages of his career in Birmingham, where he was involved in seminal work in the development of long term oxygen therapy which included use of the first prototype concentrator in the early 1970s. The safe prescription of oxygen therapy, nowadays taken for granted, owes much to those ground-breaking advances.

Tuesday 17 February 2015

Scientists identify drug that could block multiple sclerosis

Prof Luke O’Neill with flasks of inflamed white blood cells from the immune system in a laboratory in Trinity. 

Tests reveal remedy could also halt diseases such as rheumatoid arthritis and alzheimer’s

Researchers in Dublin have led an international study identifying a remarkable drug that may be able to block major diseases such as multiple sclerosis (MS), alzheimer’s, rheumatoid arthritis and most other inflammatory conditions.

Initial tests show it could instantly block MS and the effects of blood poisoning in mouse models. It also halted a rare inflammatory disease called Muckle-Wells syndrome using human blood samples as a test.

Muckle-Wells syndrome is a disorder characterised by episodes of skin rash, fever and joint pain. Progressive hearing loss and kidney damage also occur with this illness.

The drug, called MCC950, stops a very early trigger that sets off the inflammatory response to infection. While inflammation is good during infections it can cause a wide range of serious diseases if the inflammation remains in place.

“This is exciting, one of the biggest discoveries we have had,” said Prof Luke O’Neill, the chairman ofbiochemistry based in the Trinity Biomedical Sciences Institute. “It is fantastic, the thing we have been looking for for 30 years. This could be the missing compound.”

Their main discovery is being able to identify the pathway that allows the drug to block the action of a pro-inflammatory substance in the body called NLRP3.

They also confirmed that inflammatory diseases all share a common process, even though the parts of the body becoming inflamed might differ, he said.

Trinity’s collaborators included the Universities of Queensland, Michigan, Massachusetts and Bonn and their findings were published on Monday in the journal Nature Medicine. He was co-senior author with Prof Matt Cooper of Queensland, and lead author was Dr Rebecca Coll who worked with Prof O’Neill.


FREE Public Lecture on Cancer

Date: Tuesday 17 February
Time: 7-9pm

Venue: Bailey Allen Hall, Áras na Mac Léinn, NUI Galway
or you can donate on the night.
All proceeds are in aid of the following charities:
Irish Cancer Society, Cancer Care West, NBCRI and Galway Hospice.

Monday 16 February 2015

New research to guide GP management for patients with multiple chronic illnesses

The new research recommends providing continuity of care with one named GP where possible, prioritising the aspects of care that matter most to patients (such as difficulties in physical functioning), and providing regular reviews of prescriptions. The study, recently published in the British Journal of Medicine, was led by researchers at the HRB Centre for Primary Care Research in the Royal College of Surgeons in Ireland.

The paper entitled, ‘Managing patients with multimorbidity in primary care' can be viewed online on the BMJ website at http://www.bmj.com/content/350/bmj.h176

Current clinical guidelines, which recommend best practice for GPs, tend to focus on single conditions which make decision making more challenging for those patients with several co-existing conditions.

Commenting on this publication, Graham Love, Chief Executive at the Health Research Board said,
‘It is very important that care for people with multimorbidity is organised and delivered based on best research evidence in order to improve the outcomes that really matter to patients. This review offers guidance for GPs to help support this process.’

More information is available from the press release on the RCSI website.

Recent Acquisitions


Located at 362.120994 McMU










Located at 610.72 GAR



Located at 616.132 BEE

Thursday 12 February 2015

New breakthrough in stroke treatment

The clot retrieval procedure known as endo-vascular treatment was examined by researchers at the Royal College of Surgeons in Ireland and Beaumont Hospital in Dublin.
The study involved patients who had suffered an acute ischemic stroke, which is caused by a clot in the brain, and accounts for 80% of all strokes, and is published in the New England Journal of Medicine today.
It has been described as the most significant development in stroke treatment in the past two decades.
Positive outcomes for patients receiving the new “clot removal” treatment increased from 30% to 55%.
In many cases, instead of suffering major neurological disability, patients went home to resume their lives.
The overall mortality rate was reduced by 50%, from two in ten patients for standard treatment of care, to one in ten patients out of those who received the new treatment.
Professor David Williams, Associate Professor, one of the co-leads on the international study said:  "The results of this study represent the most significant development in stroke treatment in the past 20 years and will impact stroke care in Ireland and around the world.
“More than 10,000 people in Ireland are admitted to hospital with stroke annually and many of those who survive are left with significant disabilities.
“This treatment has the potential to improve survival rates and quality of life of more than 15 million people worldwide who suffer a stroke each year.
"The involvement of RCSI and Beaumont Hospital in this ground-breaking trial demonstrates the world-class expertise of clinical researchers here in Ireland," Professor Williams said.

Does the future hold a vaccine for type 1 diabetes?

Mikael Knip (lower row, on right side)

The next decade could see the development of a vaccine for type 1 diabetes, which could be given to all infants or those with a genetic susceptibility to the disease, according to a world expert.

A leading Professor of Paediatrics from Finland has suggested there is “increasing evidence” that the diabetic enterovirus may be a trigger for type 1 diabetes in children. If this is confirmed, Prof Mikael Knip of the University of Helsinki believes it may be possible to prevent about half of new cases with an anti-diabetes enterovirus vaccine.


Speaking to Irish Medical Times at the third annual 3U Partnership International Diabetes Conference, which took place at the RCSI in Dublin recently, Prof Knip accepted there was still a long way to go. “We will not have an anti-diabetic entero vaccine available within the next five to six years, but maybe within the next 10 years,” he stated.
The professor is currently the Principal Investigator for two extensive international multicentre studies on type 1 diabetes. One is TRIGR (Trial to Reduce IDDM in the Genetically at Risk) testing the hypothesis that weaning to an extensively hydrolysed formula will reduce the frequency of beta-cell autoimmunity and type 1 diabetes in children at risk. This trial is mainly funded by the National Institutes of Health (NIH).
Prof Knip addressed the 3U diabetes conference in a talk entitled ‘Current challenges in diabetes research’ on his work to date on the prevention of type 1 diabetes in children.

Wednesday 11 February 2015

'Smart' insulin hope for diabetes

Scientists are hopeful that "smart" insulins which are undergoing trials could revolutionise the way diabetes is managed.
Instead of repeated blood tests and injections throughout the day to keep blood sugar in check, a single dose of smart insulin would keep circulating in the body and turn on when needed.
Animal studies show the technology appears to work - at least in mice.
Scientists plan to move to human trials soon, PNAS journal reports.
Experts caution that it will take years of testing before treatments could become a reality for patients.
Dr Danny Chou from the Massachusetts Institute of Technology has been testing a smart insulin that he and his colleagues developed in the lab.
It is a chemically modified version of regular, long-acting insulin.
It has an extra set of molecules stuck on the end that binds it to proteins that circulate in the bloodstream. While it is attached to these, the smart insulin is in its switched off mode.
When blood sugar rises, the smart insulin switches on - glucose locks on to the smart insulin and tells it to get to work.
Dr Chou said: "My goal is to make life easier and safer for diabetics.
View more on BBC/Health here

Tuesday 10 February 2015

New Nursing & Midwifery Books


Located at 618.32686 NEO












Located at 617.0231 LeM












Located at 616.10082 CAM

New rules for eye-laser surgery

New guidelines have been drawn up for eye laser surgery amid growing concern over the use of hard-sell tactics in persuading consumers to undergo the procedure.


The guidelines from the Irish College of Ophthalmologists are voluntary, but the college says members who do not adhere to them will be refused membership.

Thousands of eye laser operations are carried out every year, the vast majority successfully. However, with complications arising in a minority of cases, the amount of litigation is increasing. At least 21 cases have been taken by individual consumers against a number of high street eye laser clinics since 2008.

Ophthalmologist and eye surgeon members of the college are increasingly concerned about the tactics used by some operators to market the procedures to customers and about the levels of pre- and aftercare provided.

“People may be led by the advertising used to think this is a trivial procedure with minimal complications,” says college president Billy Power.  “I’m amazed at the number of patients who say they never met their eye surgeon before the day of their laser operation. You wouldn’t do that with an ingrown toenail, and you certainly shouldn’t with an operation on your eye.”

The guidelines say communications with customers must not convey false information or omit material information, and must not “create unjustified expectations of results”: “Information on procedures must not trivialise the seriousness of surgery or minimise the potential risks.”

Surgeons must be registered with the Medical Council and have indemnity cover, and must be available for out-patient services and emergencies.

The information document about the surgery must be given to the patient at least 24 hours before the procedure is undertaken, to allow the patient discuss the risks and benefits involved.

Monday 9 February 2015

Study indicates e-cigarettes harm lungs

E-cigarettes generate toxic chemicals similar to those found in tobacco and may harm the lungs and immune system, new research suggests.
The findings, from a study of mice, indicate that "vaping" is far from being a safe alternative to smoking tobacco.
In the experiments, mice exposed to e-cigarette fumes suffered mild damage to their lungs and became far more susceptible to respiratory infections.
Their immune responses to both viruses and bacteria were weakened by such an extent that some animals died.
Scientists also found that e-cigarette vapour contained "free radical" toxins similar to those found in cigarette smoke and air pollution.
Free radicals are highly reactive molecules that can damage DNA and cell membranes.
Professor Shyam Biswai, from Johns Hopkins University in the US, who led the research published in the online journal Public Library of Science ONE, said: "Our findings suggest that e-cigarettes are not neutral in terms of the effects on the lungs.
"We have observed that they increase the susceptibility to respiratory infections in the mouse models. This warrants further study in susceptible individuals, such as COPD (chronic obstructive pulmonary disorder) patients who have switched from cigarettes to e-cigarettes, or to new users of e-cigarettes who may have never used cigarettes."
Co-author Dr Thomas Sussan, also from Johns Hopkins, said: "E-cigarette vapour alone produced mild effects on the lungs, including inflammation and protein damage.
"However, when this exposure was followed by a bacterial or viral infection, the harmful effects of e-cigarette exposure became even more pronounced.

Friday 6 February 2015

Health & Human Rights Conference, 6 February 2015


Under the President’s Ethics Initiative the Irish Centre for Human Rights and the College of Medicine, Nursing and Health Sciences at NUI Galway will host a one day meeting on Friday 6 February 2015 at the Aras Moyola Theatre, NUI Galway.

In the presence of President Michael D. Higgins, the meeting will examine how a human rights framework can inform ethical means to improve health and wellbeing and deliver healthcare fairly.


Click here for more information

6th Feb - International Day of Zero Tolerance for Female Genital Mutilation


Today is UN Zero Tolerance of FGM Day. An estimated 140 million women and girls have suffered FGM, an excruciating and dangerous procedure which has serious life-long health effects.

While most of these are in Africa, global migration has ensured Ireland is not immune to the practice. Based on population and migration trends, it is estimated that more than 3,700 women in Ireland have undergone FGM in their country of origin.

Yet awareness remains low, with 65 per cent of GPs in one survey saying they were unable to identify symptoms.

Up to a dozen women have been treated at the first dedicated clinic for sufferers of female genital mutilation (FGM) since it opened last year.

Most have required surgical intervention to deal with the health problems caused by the procedure, according to Dr Caitríona Henchion, medical director of theIrish Family Planning Association’s FGM clinic in Dublin.


Doctors to be obliged by law to tell patients of errors



Minister for Health Leo Varadkar said it was the equivalent of a motoring “hit and run” for doctors and health professionals to fail to make such disclosures and to live up to their duty of candour.

“I find that [behaviour] really appalling and it is not the type of medicine I was trained in.”

Mr Varadkar told the committee if doctors did adhere to their duty of candour and open disclosure and informed patients when adverse clinical outcomes had occurred, “ a lot fewer people would sue”.

The Minister said he now intended to legislate to make open disclosure a legal requirement.

Earlier, he told the committee the health service clearly has insufficient funding to address all areas of concern immediately.  Addressing the committee regarding spending for this year, he said the budget available would allow for a start to stabilising health service funding.

He claimed the health service was now in a more stable financial position than it had been for many years.

There was “undoubtedly a strong case for increased health funding in the years ahead”, he said.  However, increased spending without reform would not resolve the difficulties which the health service faced.

Govt approves bill requiring calories on menus

The Cabinet has approved proposals requiring food outlets to post the information at the point where the food is ordered, whether at tables or counters.
Drafting legislation is expected to start immediately and should be ready for enactment by next year.
Minister for Health Leo Varadkar said the move is a simple but effective way of encouraging people to choose a healthier option.
"I am very concerned about levels of overweight and obesity in Ireland. Latest figures indicate that nearly two out of every three adults, and one in four children, are overweight or obese.
"This presents real risks for health and well-being and causes a high percentage of many of the chronic diseases like heart disease, cancer and diabetes," Minister Varadkar said.
The proposed laws will require all menus, including boards, leaflets, digital menus or other forms, to display the amount of calories alongside the price in the same font size and colour. 
View on RTE/Health here

Thursday 5 February 2015

NUI Galway’s 5th International Nursing and Midwifery Conference


The 5th International Nursing and Midwifery Conference, hosted by NUI Galway’s School of Nursing and Midwifery, will be held from 30-31 March. The conference is organised in partnership with the Nursing and Midwifery Planning Development, HSE West/Mid West.

The over-arching theme of the conference, 'Building and Promoting Excellence in Practice' highlights the importance of strengthening nursing and midwifery practice at international, national, local and community levels

The conference provides an opportunity for researchers, practitioners and policy makers to get together to learn, debate and share methods of building and promoting excellence in practice. There will be oral and poster presentations and five different workshops that delegates can choose to attend.


·         Evidence - Professor Neal Maskrey, Honorary Professor of Evidence-Informed Decision Making, Keele University.
·         Compassionate Care - Professor Belinda Dewar, Professor of Practice Improvement at the University of the West of Scotland.
·         Risk and Resilience - Professor Charlotte Clarke, Head of the School of Health in Social Science, University of Edinburgh.
·         Motivation - Evelyn Gilmore, Consultant Work and Organisational Psychologist, an Accredited Psychotherapist and a Business and Executive Coach.

To avail of the early bird reduced fees please visit http://www.nursingmidwifery.ie/site/view/9/registration/ and register prior to Monday, 9 February.

Irish scientists developing bowel cancer blood tests

The test, which will search for biomarkers generated when bowel cancer starts to develop, promises to be more accurate and sensitive than existing tests.
It is being developed by scientists at the DCU-based Biomedical Diagnostics Institute in partnership with biomedical company Randox Technologies.
It is expected the new test could cost as little as €25.
Because it uses a small amount of blood it is less invasive than existing bowel cancer tests, and it is therefore leading to hopes that it may encourage more people to volunteer to be screened for the disease.
The current national bowel screening programme for those aged 60-69 has had a low uptake.
This is thought to be in part because it involves testing stool samples. Such testing is also considered slow and not entirely reliable.
Survival rates from bowel cancer are higher when the disease is caught early, after a formal diagnosis involving colonoscopy.
It is hoped the new test could lead to earlier diagnosis and a reduced need to send patients for further investigation via colonoscopy.
Bowel cancer is the second most common cause of death from cancer in Ireland.
2,500 people are diagnosed with it each year and 1,000 die from it.
The collaboration is funded by Enterprise Ireland and Randox. 

Honey and Lemon 'as good as cough mix'

THERE is no substantial evidence that expensive over-the-counter medicines are that effective in treating short-term coughs in children and adults, according to Irish researchers.
Lemon and honey can help to cure those winter coughs

Professor Susan Smith of the Royal College of Surgeons revealed researchers found the old-fashioned remedy of honey and lemon was just as effective in giving relief. The team looked at 29 trials involving 4,835 adults and children with acute cough.


"There is a high prevalence of coughs and colds at this time of year and patients often buy over-the-counter medications to alleviate their symptoms. However, our study has found little evidence to support expenditure on these and some of these medicines can occasionally result in adverse side-effects.
"Simple remedies, such as honey and lemon, can provide effective relief for coughs at a lower cost than over-the-counter medicines."
Parents should not give honey to children under one.
"We recommend that patients talk to their pharmacist or GP for advice on low-cost, safe treatments for coughs that can be prepared at home."
Darragh O' Loughlin of the Irish Pharmacy Union said: "People should talk to their pharmacist and ask if there is something they can take which will be effective for them.
"There are strong mixtures that might not be visible on the shelf. They may be able to provide something more potent."

View more here

Wednesday 4 February 2015

New Breast Cancer App - CUH

Cork University Hospital (CUH) has launched an app, FYI: Breast Cancer, to help women who are overwhelmed by medical information about cancer.

This new App explains what breast cancer is, the different types of breast cancer, what a breast cancer diagnosis means and what treatments are available. 
“As much as 90% of medical information on the internet is inaccurate or difficult to read,” says Consultant Breast Surgeon Mark Corrigan.
“To counter this, and to clearly explain the facts about breast cancer and dispel the myths, we have developed the FYI: Breast Cancer app. It has been made in a very user friendly format, and answers the most commonly asked questions.
“More and more, we see that patients attending a breast cancer clinic are using the internet for information.
“With 90% of patients using a mobile phone on a daily basis, we decided that an app would be the best way to communicate correct, easy to read information.
“We hope that the FYI: Breast Cancer app will make a major difference to the hundreds of women attending breast cancer clinics who find themselves overwhelmed by the medical information they are given.
It is hoped that the success of the app will pave the way for similar apps in other fields, such as prostate cancer, colorectal cancer and diabetes.
The FYI: Breast Cancer app is available to download on both Android and iPhone.

Communicable Diseases Update

Communicable Diseases Update Vol. 14 (1) February 2015 available via Lenus, Irish Health Repository



Tuesday 3 February 2015

Lunchtime Lecture: 'Bodies of Knowledge', Wednesday 4th February, Hardiman Building


The Special Collections Lunchtime Lectures Series 2014-2015 will continue on Wednesday Feb. 4th, in Room G011 Seminar Room in the Hardiman Building at 1pm, with "Bodies of knowledge : the early days of anatomy in Galway" by Alexander Black, Anatomy, School of Medicine.

Anatomy was one of the founding departments of Queen's College Galway and was viewed at the time as a rather distasteful, if necessary, field of study, yet to be completely separated from its sibling discipline physiology. Anatomy is a visual and tactile subject, and perhaps relies on images and illustrations more than any other academic discipline.  This talk will cover the early days of anatomy in Galway, and will illustrate the importance of anatomy to society, society to anatomy, and medical imaging to medicine.

A selection of anatomy material from the Old Library Collection will be on display during the talk, and all are welcome to the G011 Seminar Room in the Hardiman Building at 1pm.

The accompanying "Art of the Unseen" exhibition of anatomical illustration will run in the Special Collections Reading Room during the month of February.